Pulmagen Therapeutics is a development stage pharmaceutical company progressing novel therapies to treat chronic respiratory diseases including asthma, severe asthma, and COPD.

Pulmagen intends to progress its programs through Phase II proof-of-concept clinical trials and identify strategic partners for later stage clinical development.

The company has active partnered respiratory drug development programs with AstraZeneca, Chiesi, Dr. Reddy's and Teijin.